ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,80
0,76%
Dow Jones
38 834,86
0,15%
DAX
18 131,97
0,32%
Brent Oil
84,785
1,05%
Bitcoin
65 106,52
-2,07%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Trilogy International Partners Inc (TRL)

  7. Trilogy International Partners Inc (TRL) Actualités

TRL

Trilogy International Pa... (TRL)

Trilogy International Partners Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:TRL
DateHeureSourceTitreSymboleSociété
07/02/202218h15PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TRL.WTTSX:TRLTrilogy International Partners Inc
07/02/202218h12PR Newswire (Canada)IIROC Trading Halt - TRL.WTTSX:TRLTrilogy International Partners Inc
07/10/202114h18PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TRLTSX:TRLTrilogy International Partners Inc
07/10/202114h16PR Newswire (Canada)IIROC Trade Resumption - TRLTSX:TRLTrilogy International Partners Inc
06/10/202121h10PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TRLTSX:TRLTrilogy International Partners Inc
06/10/202121h09PR Newswire (Canada)IIROC Trading Halt - TRLTSX:TRLTrilogy International Partners Inc
15/02/201923h12PR Newswire (US)Phoenix Tower International expands footprint in South America with acquisition of 600 wireless communication tower sites fro...TSX:TRLTrilogy International Partners Inc
08/09/201723h45PR Newswire (Canada)S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian IndicesTSX:TRLTrilogy International Partners Inc
08/09/201723h42PR Newswire (Canada)S&P Dow Jones Indices annonce des modifications aux indices canadiens S&P/TSXTSX:TRLTrilogy International Partners Inc
16/03/201512h30PR Newswire (Canada)Endo Pharmaceuticals Announces the Launch of NATESTO™ (testosterone nasal gel), the First and Only Nasal Gel for Testostero...TSX:TRLTrilogy International Partners Inc
09/12/201413h00PR Newswire (Canada)Endo Completes Acquisition of Rights to Natesto™ Testosterone Nasal GelTSX:TRLTrilogy International Partners Inc
01/12/201414h34InvestorsHub NewsWireEDISON EQUITY RESEARCH - TRIMEL PHARMACEUTICALSTSX:TRLTrilogy International Partners Inc
06/08/201406h27InvestorsHub NewsWireTrimel Pharmaceuticals - Seeking positive EBITDA with EstraceTSX:TRLTrilogy International Partners Inc
30/07/201415h15Marketwired CanadaTrimel Completes Private Placement of Common SharesTSX:TRLTrilogy International Partners Inc
28/07/201416h12InvestorsHub NewsWireTrimel Pharmaceuticals - A closer look at Tefina Phase II FOD resultsTSX:TRLTrilogy International Partners Inc
26/07/201400h31PR Newswire (Canada)Update to Early Warning Report for Trimel Pharmaceuticals CorporationTSX:TRLTrilogy International Partners Inc
17/07/201419h53PR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - TRLTSX:TRLTrilogy International Partners Inc
17/07/201419h40Marketwired CanadaTrimel Pharmaceuticals Acquires Canadian Rights to Estrace®TSX:TRLTrilogy International Partners Inc
18/06/201421h00MarketwiredTrimel to Present at the JMP Securities Healthcare ConferenceTSX:TRLTrilogy International Partners Inc
16/06/201421h20MarketwiredTrimel to Present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceTSX:TRLTrilogy International Partners Inc
16/06/201412h00MarketwiredTrimel Reports Additional Results From Tefina(TM) Phase II Clinical TrialTSX:TRLTrilogy International Partners Inc
13/06/201401h41MarketwiredTrimel Announces Voting Results for 2014 Annual General and Special Shareholders' MeetingTSX:TRLTrilogy International Partners Inc
29/05/201403h06PR Newswire (US)Trimel Receives FDA Approval for Natesto(TM) Nasal Gel to Treat Men with Low TestosteroneTSX:TRLTrilogy International Partners Inc
29/05/201401h28PR Newswire (Canada)Trimel Receives FDA Approval for Natesto™ Nasal Gel to Treat Men with Low TestosteroneTSX:TRLTrilogy International Partners Inc
28/05/201412h30PR Newswire (US)Trimel Pharmaceuticals Announces Positive Phase II Results for Tefina™TSX:TRLTrilogy International Partners Inc
08/05/201423h29MarketwiredTrimel Provides Corporate Update and First Quarter 2014 Financial ResultsTSX:TRLTrilogy International Partners Inc
02/05/201421h37MarketwiredTrimel to Report First Quarter 2014 Results and Host Conference Call to Update InvestorsTSX:TRLTrilogy International Partners Inc
06/03/201401h33MarketwiredTrimel Reports Fourth Quarter and Full Year 2013 Financial ResultsTSX:TRLTrilogy International Partners Inc
27/02/201422h45MarketwiredTrimel to Report Financial Results for 2013 and Host Conference Call to Update InvestorsTSX:TRLTrilogy International Partners Inc
21/02/201421h44MarketwiredTrimel Announces Closing of $10.5 Million Private Placement of Common SharesTSX:TRLTrilogy International Partners Inc
 Showing the most relevant articles for your search:TSX:TRL

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
CAP
Capgemini
EU
BNP
BNP Paribas
EU
ML
Michelin
EU
ACA
Credit Agricole
NYSE
KO
Coca Cola
EU
EN
Bouygues
EU
BEL20
Bel 20
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
EU
RNO
Renault
EU
VK
Vallourec
EU
CS
Axa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés